Reply to Fusco et al

Affiliations

¹ Noam Yarom, DMD, Sheba Medical Center, Tel Hashomer, and Tel Aviv University, Tel Aviv, Israel; Douglas E. Peterson, DMD, PhD, School of Dental Medicine and Neag Comprehensive Cancer Center, UConn Health, Farmington, CT; Kari Bohlke, ScD, American Society of Clinical Oncology, Alexandria, VA; and Deborah P. Saunders, BSc, DMD, North East Cancer Center, Health Sciences North, Northern Ontario School of Medicine, Sudbury, Ontario, Canada.

Comment

Noam Yarom et al. JCO Oncol Pract. 2020 Mar.

. 2020 Mar;16(3):145-146.

doi: 10.1200/JOP.19.00716. Epub 2020 Jan 24.

¹ Noam Yarom, DMD, Sheba Medical Center, Tel Hashomer, and Tel Aviv University, Tel Aviv, Israel; Douglas E. Peterson, DMD, PhD, School of Dental Medicine and Neag Comprehensive Cancer Center, UConn Health, Farmington, CT; Kari Bohlke, ScD, American Society of Clinical Oncology, Alexandria, VA; and Deborah P. Saunders, BSc, DMD, North East Cancer Center, Health Sciences North, Northern Ontario School of Medicine, Sudbury, Ontario, Canada.

No abstract available

Comment on

Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice Guideline.
Yarom N, Shapiro CL, Peterson DE, Van Poznak CH, Bohlke K, Ruggiero SL, Migliorati CA, Khan A, Morrison A, Anderson H, Murphy BA, Alston-Johnson D, Mendes RA, Beadle BM, Jensen SB, Saunders DP. Yarom N, et al. J Clin Oncol. 2019 Sep 1;37(25):2270-2290. doi: 10.1200/JCO.19.01186. Epub 2019 Jul 22. J Clin Oncol. 2019. PMID: 31329513
Comment on Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice Guideline Summary.
Fusco V, Santini D, Campisi G, Bertoldo F, Lanzetta G, Ibrahim T, Bertetto O, Numico G, Addeo A, Berruti A, Bettini G, Saia G, Bedogni A. Fusco V, et al. JCO Oncol Pract. 2020 Mar;16(3):142-145. doi: 10.1200/JOP.19.00645. Epub 2020 Jan 24. JCO Oncol Pract. 2020. PMID: 32048935 No abstract available.